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Abstract: Six weeks BALB/c mice were fed with an atherogenic diet for 24 weeks and purified water ad libitum. An experimental 
group was given betanidin, orally, during the last 40 days of the experiment at a dose of 9.6 mg per mouse per day. Negative  
controls were fed with standard rodent chow only. Glycemia was measured at the end of the experiment, after overnight fasting. 
The group treated with betanidin presented a highly significant reduction of 50.94% compared to positive controls. We conclude 
that betanidin reduces glycemia in BALB/c mice by an unidentified mechanism. 
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Introduction 
Betalains are hydrophilic nitrogenous pigments found in 
most plants from the order Caryophyllales. These pigments are 
mainly found in the vacuoles of all their tissues1. Betalains 
confer these plants their yellow, orange, red and violet  
colours2 and are powerful antioxidants3,4. In the course of 
evaluating the antioxidant properties of betanidin2, the  
aglycone of the most common betalain, in the pathophysiology 
of atherosclerosis, we found that betanidin has an effect in the 
blood glucose levels in BALB/c mice fed with an atherogenic 
diet. 
 
Results and Discussion 
Betanidin treatment produced a 50.94% reduction in the 
glycemia of mice as compared to the mean from the positive 
control group (Table 1). This reduction was highly significant 
(p < 0.00001) compared to both control groups (Figure 1). 
There were not significant differences between positive and 
negative controls. 
The hypoglycemic effect observed for betanidin we describe 
here has not been reported before. There are also not reports of 
any effect of betalains in the insulin or glucose tolerance. As 
with other betalains3,6–9, the main biological action of 
betanidin known to date in animal biomolecules is its  
antioxidant capacity10. Betalains have also been shown to  
induce the expression of quinone reductases11, to inhibit the 
expression of ICAM-112 and to decrease the DNA methyl 
transferase activity13. However, none of the effects mentioned 
can directly explain the hypoglycemic effect observed.  
Unfortunately, we could not measure glucose or insulin  
tolerance or levels of expression of the second; therefore, it is 
not possible to determine if these two factors suffer changes 
with the administration of betanidin. Moreover, we can only 
determine that betanidin produce a hypoglycemic effect but it 
is not possible with the available information to determine if it 
has also an anti-hyperglycemic effect. We did not quantify the 
hypoglycemic effect with different doses of betanidin nor the 
presence of this effect in other betalains. In respect to the latter, 
since the antioxidant capacity and the other effects mentioned 
before are considered to be present in all betalains3,4,6–8,10–12,14,15, 
it may be possible that the hypoglycemic effect is  
present in all this group of molecules; further studies will  
determine if this is the case. 
 
Experimental Section 
Animals. Six weeks inbred BALB/c mice (Harlan 
Laboratories, Indiana, USA) were randomly assigned into 
cages (n = 5 per cage), acclimatized for 2 weeks in a 12 hours 
Table 1. Means of glycemia and SEM of the three experimental 
groups 
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ligth/12 hours darkness cycle. They were fed with a Teklad 
Global Diet 2018S (Harlan Laboratories, Indiana, USA) and 
purified water ad libitum. At the start of the experiment, the 
diet of the animals was changed to an atherogenic rodent diet 
TD.02028 (15.5% kcal/kcal protein; 41.9% kcal/kcal 
carbohydrates; 42.6 % kcal/kcal fat) (Harlan Laboratories, 
Indiana, USA). The negative group (n = 16) continued to be 
fed with the Teklad Global Diet 2018S. Positive control (n = 
13) and betanidin (n = 12) groups continued with the 
atherogenic diet for 24 weeks. During the last 40 days of the 
experiment, betanidin was given orally to the betanidin group 
at a dose of 9.6 mg per mouse per day. After an overnight 
fasting (water was not suspended), decapitation was performed 
as part of a parallel experimental protocol. The findings here 
described resulted as parallel data from a bigger research 
project evaluating the effect of betanidin in dyslipidemia. All 
animal procedures were approved by the Bioethics Committee 
from the University of Colima and conducted in accordance 
with the Guide for the Care and Use of Laboratory Animals 
published by the US National Institutes of Health. 
 
Betanidin Obtainment. Betanin extraction and purification 
Fresh red-purple pitaya fruits (Hylocereus ocamponis) were 
purchased from a commercial plantation in Jalisco (Mexico). 
Upon arrival of fruits, they were washed and peeled by hand. 
Skins were discarded and the fruit flesh was macerated in a 
blender until being completely homogenized. For pigment 
extraction, 1 part of this sample was shaken with 2 parts of 
solvent for 5 minutes and allowed to stand for 15 min; solvents 
used were 80% acetone, 80% methanol and ultra purified 
water. After, the mixture was filtrated through a nylon cloth 
and centrifuged at 3500 rpm for 15 min. Afterwards, the 
supernatant was filtered through YM-10 membranes 
(Millipore) to remove proteins, and the filtrate was used for 
pigment analysis and further purification. All was performed 
at room temperature. Betanin was purified by FPLC and 
confirmed by HPLC as performed by Gandía-Herrero, et al5. 
Afterwards, it was aliquoted and kept at – 80 °C in the dark 
until use. 
Betanidin synthesis An enzymatic hydrolysis of purified 
betanin with -glucosidase was performed as stated by 
Gandía-Herrero, et al5. Transformation was complete 
according to HPLC analysis. 
 
Blood Glucose Levels. A OneTouch Ultra test strip 
(LifeScan, California, USA) was filled with a drop of blood 
immediately after euthanasia. Blood glucose levels were 
measured using a OneTouch UltraMini meter (LifeScan, 
California, USA) and the results were expressed in mg/dl. 
Calculations and graphs were carried out in the Microsoft 
Excel software (Microsoft Corporation, Washington, USA). 
 
Statistical Analysis. Data represent mean SEM. One-way 
ANOVA test was used as a measure of significance.  
Differences with p values of less than 0.05 were considered 
statistically significant. Statistical analyses were carried out in 
the Microsoft Excel software (Microsoft Corporation,  
Washington, USA). 
 
Electronic Supplementary Material 
Supplementary material is available in the online version of 
this article at http://dx.doi.org/ 10.1007/s13659-012-0034-z 
and is accessible for authorized users. 
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Figure 1.  Effect of betanidin in blood glucose levels. Oral 
administration of betanidin produced a significant reduction 
of around 50% in the blood glucose levels in BALB/c mice.  
* = p < 0.00001 
